bendamustine hydrochloride has been researched along with Infections in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 9 (81.82) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Abramson, JS; Bartlett, NL; Booth, AM; Brander, DM; Brown, JR; Byrd, JC; Coutre, S; Ding, W; Erba, H; Kuzma, CS; Larson, RA; Little, RF; Litzow, M; Mandrekar, SJ; Nattam, S; Owen, C; Ruppert, AS; Smith, SE; Stone, RM; Woyach, JA | 1 |
| Cheson, BD; Nair, KS; Penne, M; Sarraf Yazdy, M | 1 |
| Castillo, JJ; Olszewski, AJ; Reagan, JL | 1 |
| Farmakiotis, D; Freedman, A; Fung, M; Gu, X; Jacobsen, E; Koo, S; Nguyen, PL; Prestes, D | 1 |
| Cheson, BD; Gehan, E; Ramzi, P; Ujjani, C; Wang, H; Wang, Y | 1 |
| Avigdor, A; Aviv, A; Avivi, I; Gafter-Gvili, A; Gurion, R; Kedmi, M; Mizrahi, N; Nagler, A; Perry, C; Raanani, P; Ram, R; Ribakovsky, E; Vidal, L | 1 |
| Balser, C; Barth, J; Blau, W; Boeck, HP; Brugger, W; Hahn, L; Hinke, A; Kaiser, U; Kauff, F; Losem, C; Mueller, L; Niederle, N; Rummel, M; Sandherr, M; Stauch, M; Vereshchagina, J; von Gruenhagen, U; Weidmann, E; Welslau, M | 1 |
| Gafter-Gvili, A; Polliack, A | 1 |
| Gafter-Gvili, A; Gurion, R; Raanani, P; Shpilberg, O; Vidal, L | 1 |
| Cheson, BD; Cohen, P; Herst, JA; Lemieux, B; Robinson, KS; Schwartzberg, LS; Tulpule, A; van der Jagt, RH; Williams, ME | 1 |
| Alizadeh, AA; Hosein, PJ; Lossos, IS; Maeda, LS; Warsch, S | 1 |
2 review(s) available for bendamustine hydrochloride and Infections
| Article | Year |
|---|---|
Bendamustine associated immune suppression and infections during therapy of hematological malignancies.
Topics: Agammaglobulinemia; Antibiotic Prophylaxis; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Hematologic Neoplasms; Humans; Immune System; Immunosuppressive Agents; Infections; Lymphopenia | 2016 |
Bendamustine-associated infections-systematic review and meta-analysis of randomized controlled trials.
Topics: Antineoplastic Agents, Alkylating; Bendamustine Hydrochloride; Humans; Infections; Randomized Controlled Trials as Topic | 2017 |
4 trial(s) available for bendamustine hydrochloride and Infections
| Article | Year |
|---|---|
Adverse event burden in older patients with CLL receiving bendamustine plus rituximab or ibrutinib regimens: Alliance A041202.
Topics: Adenine; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Atrial Fibrillation; Bendamustine Hydrochloride; Female; Follow-Up Studies; Humans; Hypertension; Infections; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Piperidines; Prognosis; Rituximab; Survival Rate | 2021 |
Ofatumumab and bendamustine in previously treated chronic lymphocytic leukemia and small lymphocytic lymphoma.
Topics: Aged; Aged, 80 and over; Anemia; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Disease-Free Survival; Drug Administration Schedule; Fatigue; Female; Humans; Infections; Infusions, Intraventricular; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Neutropenia; Retreatment; Treatment Outcome | 2015 |
Bendamustine plus rituximab versus fludarabine plus rituximab for patients with relapsed indolent and mantle-cell lymphomas: a multicentre, randomised, open-label, non-inferiority phase 3 trial.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Disease-Free Survival; Female; Humans; Infections; Lymphoma, Mantle-Cell; Male; Middle Aged; Recurrence; Retreatment; Rituximab; Survival Rate; Treatment Outcome; Vidarabine | 2016 |
Phase II multicenter study of bendamustine plus rituximab in patients with relapsed indolent B-cell and mantle cell non-Hodgkin's lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Female; Gastrointestinal Diseases; Headache; Hematologic Diseases; Humans; Infections; Kaplan-Meier Estimate; Lymphoma, B-Cell; Lymphoma, Mantle-Cell; Male; Middle Aged; Nausea; Neoplasm Recurrence, Local; Nitrogen Mustard Compounds; Remission Induction; Rituximab | 2008 |
5 other study(ies) available for bendamustine hydrochloride and Infections
| Article | Year |
|---|---|
Extended Follow-up of Patients Treated With Bendamustine for Lymphoid Malignancies.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Female; Follow-Up Studies; Humans; Infections; Leukemia, Lymphoid; Lymphoma; Male; Middle Aged; Retreatment; Retrospective Studies; Treatment Outcome; Young Adult | 2017 |
Late infections and secondary malignancies after bendamustine/rituximab or RCHOP/RCVP chemotherapy for B-cell lymphomas.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Cyclophosphamide; Doxorubicin; Female; Humans; Infections; Lymphoma, B-Cell; Male; Middle Aged; Neoplasms, Second Primary; Prednisone; Rituximab; Vincristine | 2018 |
Increased Risk of Infectious Complications in Older Patients With Indolent Non-Hodgkin Lymphoma Exposed to Bendamustine.
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Cohort Studies; Female; Humans; Infections; Lymphoma, Non-Hodgkin; Male; Multivariate Analysis; Risk Factors | 2019 |
Infections associated with bendamustine containing regimens in hematological patients: a retrospective multi-center study.
Topics: Aged; Antineoplastic Agents, Alkylating; Bendamustine Hydrochloride; Biomarkers; Female; Hematologic Diseases; Hospitalization; Humans; Incidence; Infections; Israel; Lymphoproliferative Disorders; Male; Middle Aged; Retrospective Studies; Risk Factors | 2016 |
A retrospective study evaluating the efficacy and safety of bendamustine in the treatment of mantle cell lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Bendamustine Hydrochloride; Female; Humans; Infections; Kaplan-Meier Estimate; Lymphoma, Mantle-Cell; Male; Middle Aged; Neutropenia; Nitrogen Mustard Compounds; Retrospective Studies; Thrombocytopenia; Treatment Outcome | 2012 |